# Cathay General Bancorp: financial statements, quarterly

CATY · Nasdaq · CIK 861842 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/caty.md) · [Financials](/companies/caty/financials.md) · [Filings](/companies/caty/filings.md) · [Insiders](/companies/caty/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/caty/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.8](/filings/0001437749-24-034150.md) | [11.6 d](/filings/0001437749-26-006157.md) | [11.9](/filings/0001437749-25-015797.md) | [12.9](/filings/0001437749-25-025772.md) | [13.8](/filings/0001437749-25-033885.md) | [13.6 d](/filings/0001437749-26-006157.md) | [13.1](/filings/0001437749-26-015940.md) | [12.3](/filings/0001437749-26-026554.md) | [14.5](/filings/0001437749-25-033885.md) | [13.9 d](/filings/0001437749-26-006157.md) | [14.5](/filings/0001437749-26-015940.md) | [15.9](/filings/0001437749-26-026554.md) |
| Interest expense | $m | [138](/filings/0001437749-23-030959.md) | [151 d](/filings/0001437749-24-005948.md) | [164](/filings/0001437749-24-015384.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [10.1](/filings/0001437749-24-034150.md) | [10.5 d](/filings/0001437749-26-006157.md) | [8.6](/filings/0001437749-25-015797.md) | [5.8](/filings/0001437749-25-025772.md) | [10.6](/filings/0001437749-25-033885.md) | [6.6 d](/filings/0001437749-26-006157.md) | [17.2](/filings/0001437749-26-015940.md) | [18.8](/filings/0001437749-26-026554.md) | [16.1](/filings/0001437749-25-033885.md) | [23.0 d](/filings/0001437749-26-006157.md) | [23.1](/filings/0001437749-26-015940.md) | [26.5](/filings/0001437749-26-026554.md) |
| Net income | $m | [82.4](/filings/0001437749-24-034150.md) | [82.5 d](/filings/0001437749-26-006157.md) | [71.4](/filings/0001437749-24-015384.md) | [66.8](/filings/0001437749-25-025772.md) | [67.5](/filings/0001437749-25-033885.md) | [80.2 d](/filings/0001437749-26-006157.md) | [69.5](/filings/0001437749-26-015940.md) | [77.5](/filings/0001437749-26-026554.md) | [77.7](/filings/0001437749-25-033885.md) | [90.5 d](/filings/0001437749-26-006157.md) | [86.9](/filings/0001437749-26-015940.md) | [92.2](/filings/0001437749-26-026554.md) |
| Diluted EPS | $ per share | [1.13](/filings/0001437749-24-034150.md) | not reported | [0.98](/filings/0001437749-25-015797.md) | [0.92](/filings/0001437749-25-025772.md) | [0.94](/filings/0001437749-25-033885.md) | not reported | [0.98](/filings/0001437749-26-015940.md) | [1.10](/filings/0001437749-26-026554.md) | [1.13](/filings/0001437749-25-033885.md) | not reported | [1.29](/filings/0001437749-26-015940.md) | [1.37](/filings/0001437749-26-026554.md) |
| Basic EPS | $ per share | [1.14](/filings/0001437749-24-034150.md) | not reported | [0.98](/filings/0001437749-25-015797.md) | [0.92](/filings/0001437749-25-025772.md) | [0.94](/filings/0001437749-25-033885.md) | not reported | [0.99](/filings/0001437749-26-015940.md) | [1.11](/filings/0001437749-26-026554.md) | [1.13](/filings/0001437749-25-033885.md) | not reported | [1.30](/filings/0001437749-26-015940.md) | [1.38](/filings/0001437749-26-026554.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [22.8](/filings/0001437749-23-030959.md) | [23.1](/filings/0001437749-25-005749.md) | [23.4](/filings/0001437749-24-015384.md) | [23.2](/filings/0001437749-24-025522.md) | [23.3](/filings/0001437749-24-034150.md) | [23.1](/filings/0001437749-26-006157.md) | [23.2](/filings/0001437749-25-015797.md) | [23.7](/filings/0001437749-25-025772.md) | [24.1](/filings/0001437749-25-033885.md) | [24.2](/filings/0001437749-26-026554.md) | [24.0](/filings/0001437749-26-015940.md) | [24.7](/filings/0001437749-26-026554.md) |
| Total liabilities | $bn | [20.2](/filings/0001437749-23-030959.md) | [20.3](/filings/0001437749-25-005749.md) | [20.6](/filings/0001437749-24-015384.md) | [20.4](/filings/0001437749-24-025522.md) | [20.4](/filings/0001437749-24-034150.md) | [20.2](/filings/0001437749-26-006157.md) | [20.3](/filings/0001437749-25-015797.md) | [20.8](/filings/0001437749-25-025772.md) | [21.2](/filings/0001437749-25-033885.md) | [21.3](/filings/0001437749-26-026554.md) | [21.1](/filings/0001437749-26-015940.md) | [21.6](/filings/0001437749-26-026554.md) |
| Long-term debt | $bn | [0.1](/filings/0001437749-23-030959.md) | [0.1](/filings/0001437749-25-005749.md) | [0.1](/filings/0001437749-24-015384.md) | [0.1](/filings/0001437749-24-025522.md) | [0.1](/filings/0001437749-24-034150.md) | [0.1](/filings/0001437749-26-006157.md) | [0.1](/filings/0001437749-25-015797.md) | [0.1](/filings/0001437749-25-025772.md) | [0.1](/filings/0001437749-25-033885.md) | [0.1](/filings/0001437749-26-026554.md) | [0.1](/filings/0001437749-26-015940.md) | [0.1](/filings/0001437749-26-026554.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.6](/filings/0001437749-24-034150.md) | [2.7](/filings/0001437749-26-006157.md) | [2.8](/filings/0001437749-24-015384.md) | [2.8](/filings/0001437749-25-033885.md) | [2.8](/filings/0001437749-25-033885.md) | [2.8](/filings/0001437749-26-026554.md) | [2.9](/filings/0001437749-26-026554.md) | [2.9](/filings/0001437749-26-026554.md) | [2.9](/filings/0001437749-25-033885.md) | [2.9](/filings/0001437749-26-026554.md) | [3.0](/filings/0001437749-26-026554.md) | [3.0](/filings/0001437749-26-026554.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [107 d](/filings/0001437749-24-034150.md) | [65.8 d](/filings/0001437749-26-006157.md) | [88.2](/filings/0001437749-25-015797.md) | [72.9 d](/filings/0001437749-25-025772.md) | [81.2 d](/filings/0001437749-25-033885.md) | [86.8 d](/filings/0001437749-26-006157.md) | [99.0](/filings/0001437749-26-015940.md) | [64.0 d](/filings/0001437749-26-026554.md) | [151 d](/filings/0001437749-25-033885.md) | [55.1 d](/filings/0001437749-26-006157.md) | [98.3](/filings/0001437749-26-015940.md) | [237 d](/filings/0001437749-26-026554.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001437749-24-034150.md) | [1.8 d](/filings/0001437749-26-006157.md) | [0.9](/filings/0001437749-25-015797.md) | [0.5 d](/filings/0001437749-25-025772.md) | [1.2 d](/filings/0001437749-25-033885.md) | [1.0 d](/filings/0001437749-26-006157.md) | [2.7](/filings/0001437749-26-015940.md) | [1.3 d](/filings/0001437749-26-026554.md) | [0.5 d](/filings/0001437749-25-033885.md) | [0.5 d](/filings/0001437749-26-006157.md) | [2.3](/filings/0001437749-26-015940.md) | [3.7 d](/filings/0001437749-26-026554.md) |
| Dividends paid | $m | [24.7 d](/filings/0001437749-24-034150.md) | [24.7 d](/filings/0001437749-26-006157.md) | [24.7](/filings/0001437749-25-015797.md) | [24.8 d](/filings/0001437749-25-025772.md) | [24.3 d](/filings/0001437749-25-033885.md) | [24.2 d](/filings/0001437749-26-006157.md) | [23.9](/filings/0001437749-26-015940.md) | [23.8 d](/filings/0001437749-26-026554.md) | [23.2 d](/filings/0001437749-25-033885.md) | [22.9 d](/filings/0001437749-26-006157.md) | [25.4](/filings/0001437749-26-015940.md) | [25.4 d](/filings/0001437749-26-026554.md) |
| Share repurchases | $m | [(0.0) d](/filings/0001437749-23-030959.md) | [(0.0) d](/filings/0001437749-26-006157.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [74.2](/filings/0001437749-23-030959.md) | [72.9](/filings/0001437749-24-015384.md) | [72.8](/filings/0001437749-24-025522.md) | [72.9](/filings/0001437749-24-034150.md) | [73.0](/filings/0001437749-25-015797.md) | [72.8](/filings/0001437749-25-025772.md) | [72.0](/filings/0001437749-25-033885.md) | [70.7](/filings/0001437749-26-015940.md) | [70.2](/filings/0001437749-26-026554.md) | [69.0](/filings/0001437749-25-033885.md) | [67.4](/filings/0001437749-26-015940.md) | [67.3](/filings/0001437749-26-026554.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 66,713,820 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026554.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.